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AbstractLoaded erythrocytes, as drug carrier system, has tremendous potential to carry 
outside specificity and sustained release of drug. Thereby, enhancing therapeutic index and 
minimize the dose and adverse effects as well as improvement patient compliance. In the 
present paper, erythrocytes loaded Ribavirin with the aim to benefit the reticuloendothelial 
system (RES) targeting potential of the carrier cells. Endocytosis technique was used for 
Ribavirin loading in erythrocytes and the entire loading procedure was evaluated and 
validated. The in-vitro release of carrier erythrocytes was characterized, as well as the 
hematologicalindices, osmotic fragility and SEM analysis.The maximum loaded amount 
and entrapment efficiency were found to be 9.58 ± 0.045 mg and 38.3% at 25mg/ml of 
Ribavirin concentration after 60 minutes incubation time at 37
o
C with 88.42% cell 
recovery.TheIn vitroRibavirin release was found to obey Higuchi diffusion kinetics. 
Hematological parameters ofRibavirin loaded erythrocyteswere significantly differ from 
native erythrocytesat (p≤ 0.01). It was found that the meancorpuscular volume value was 
increased, while the mean corpuscular hemoglobin and the mean corpuscular hemoglobin 
content values were decreased. Also, the osmotic fragility behaviors of Ribavirin loaded 
erythrocytes were significantly decreasedat (p≤ 0.001). The scanning electron microscope 
of Ribavirin loaded erythrocytes show significant changes in the cell surface and 
morphology with rough cell surface and small lesions. The highly changed erythrocyte 
shape and morphology being one of the main determinants in erythrocytes disappearance 
kinetics in circulation, can be potentially beneficial in terms of successful cell targeting to 
RES which in turn leads to the improved Ribavirin effects on RES-mediated immune 
responses. 
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INTRODUCTION 
Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that 
primarily affects the liver. The virus persists in the liver in about 75% to 85% of those 
initially infected.  It often leads to liver disease and occasionally cirrhosis. In some cases, 
those with cirrhosis will develop complications such as liver failure, liver cancer, 
or esophageal and gastric varices (R). Ribavirin as anti viraldrug hastherapeutic efficacy 
against HCV, in a combination with other drugs, but Ribavirin has many adverse effects; 
some of which are severe as hemolytic anemia which sometimes necessitate patients to 
discontinue therapy, giving supplement therapy as erythropoietin, or at last blood 
transfusion is needed.To overcome or minimize the risk of Ribavirin adverse effects, 
Ribavirin should be targeted to reticuloendothelial system (RES) mainly to the liver.  
Erythrocyte has been exploited as potential carrier for bioactive substances, 
especially biopharmaceuticals, in recent decades 
1–3
. Erythrocytes are preferred as a drug 
carrier system because they have many advantages as availability in abundant cells in the 
body, biocompatibility, biodegradability, loading with a variety of drugs 
4
 and considerable 
circulation life-span of the autologous carrier erythrocytes which allow them to serve as 
prolonged release intravenous reservoirs for various drugs 
1,5,6
. On the other hand, 
abnormal or aged erythrocytes are destructed or phagocytosed by the RES and they can be 
used as drug targeting carriers to RES organs mainly liver, spleen and kidney 
7–10
. 
  
The drugs or bioactive substances can be successfully loaded or entrapped into 
erythrocytes by different methods as osmosis based method (e.g. hypotonic dilution, 
preswelling and hypotonic dialysis methods), chemical method (e.g., chemical perturbation 
of the erythrocyte membrane), an electrical pulse method and endocytosis method
11
.  
In this paper, the human erythrocytes have been loaded by Ribavirin using 
endocytosis method and the in vitro characteristics of the prepared cellular carriers have 
been evaluated. The obtained results from this study such as remarkable shape and 
morphological changes erythrocytes make it possible to target the Ribavirin a high dose in 
a short time period, thereby potentially augmenting the biological response using a 
relatively low drug dose, consequently diminishing of deleterious adverse effects of 
Ribavirin as hemolytic anemia. This benefit is intended as the scope of work of this study. 
Methodology 
Materials 
Ribavirin was obtained as gift from MEMPHIS, El-Amirya - Cairo –Egypt; Sodium 
chloride, potassium dihydrogen phosphate, Disodium hydrogen phosphate, calcium 
chloride and d- glucose were supplied from El-Nasr Pharm. Chem. Company, (Cairo, 
Egypt);Potassium chloride is provided from Flukachemie AGCH, Switzerland; Membrane 
PTFE (0.2 μm) Disposable syringe filter from Macherey-Nagel GmbH, Germany; 
Magnesium Chloride hexahydrateand methanol were purchased from El-Gomeria pharm 
company (Cairo- Egypt); Adenosine 5-Triphosphate was obtained as a gift from SIGMA - 
pharmaceutical industries -Quesna city - Egypt. 
Collection of specimen 
The blood specimens were collected from apparently healthy donors not suffered 
from acute and chronic diseases. Blood samples were collected in heparinized tubes.  
Preparation of erythrocyte suspension 
The collected specimens were centrifuged for 5 min at 5000 rpm(Biofuge Primo 
centrifuge maximum 17.000 rpm (England)). The plasma and the buffy coat were removed 
by aspiration.Erythrocytes were washed three times in cold (PBS) with centrifugation for 5 
min at 5000rpm, then the hematocrit was adjusted to 45% using PBS (Selvamani et al.; 
2015; Pierige et al.; 2008). 
Ribavirin loaded erythrocytes by endocytosis technique 
In 2 ml eppendorff tubes, 400 µl of washed erythrocytes were added to 400 µl of 
previous prepared loading buffer containing different concentrations of Ribavirin, gentle 
mixing to avoid blood hemolysis and the obtained suspension was incubated for different 
times at 37 
o
C (Oven, Heraeus, UT 5060 E (Germany)). The final obtained suspension was 
centrifuged for 5 min at 5000 rpm and the supernatant was discarded. The obtained pellet 
was washed for 2 times in cold BPS with centrifugation for 5 min at 5000 rpm. 
Effect of Ribavirin concentrations on the loading efficiency 
To determine the effect of Ribavirin concentration on loading efficiency, different 
drug concentrations (10 mg, 15 mg, 20 mg, and 25 mg) were used for all selected 
incubation times. The results were compared to obtain the more suitable concentration for 
loading process which produce most excellent loading parameters (Millán et al.; 2004; 
Madhavi et al., 2013) 
Effect of incubation times on the loading efficiency 
To determine the effect of time on loading efficiency, the loading process was done 
for the selected concentrations for different times (15, 30 and 60 minutes) and the results 
were compared (Millán et al.; 2008; Millán et al.; 2004; Madhavi et al.; 2013). 
Ribavirin extraction process from loaded erythrocytes for assay  
  
To determine the amount of loaded Ribavirin, the erythrocyte pellets were treated 
with 400µl of distilled water and strong shaking to ensure erythrocyte hemolysis, then 
deposition of protein via addition of 1ml methanol, mixing by shaking and using 
vortex(Vortex mixer type Janke& Kunkel (Germany).The resultant hemolysate was 
centrifuged at 13000 rpm for 15 minutes, and then the supernatant was taken and filtered 
using 0.2 Millipore disposable syringe filter, and complete the volume to 10 ml by water. 
1µl of filtrate was injected to the chromatograph (HPLC) Agilent 1100 liquid 
chromatography system (Agilent, Palo Alto, CA, USA). 
Characterization of the prepared Ribavirin loaded erythrocytes by previous two methods   
Loading parameters 
To evaluate the final erythrocyte carriers, three indices were defined as loading 
parameters (loaded amount, entrapment efficiency and cell recovery) (Hamidi et al.; 2007): 
1. Loaded amount: The total amount of Ribavirin entrapped in 0.4 ml of the final packed 
erythrocytes. 
2. Entrapment efficiency: The percentage ratio of the loaded amount ofRibavirin to the 
amount added during the entire loading process. 
3. Cell recovery: The percentage ratio of the hematocrit value of the final loaded cells to 
that of the initial packed cells, both measured using equal suspension volumes. 
Hematological Indices 
Normal erythrocytes, erythrocytes suspended in PBS and Ribavirin-loaded 
erythrocytes were counted. The mean corpuscular volume (MCV: the estimated average 
cell volume), the mean corpuscular hemoglobin (MCH: the estimated average hemoglobin 
content per each cell), and the mean corpuscular hemoglobin content (MCHC: the 
estimated hemoglobin content per 100 ml of cell volume) were measured using 
Hematology analyzer (Hematology analyzer Swelab auto counter 920 – Eo+ - 126 13 
Stockholm Sweden). 
Osmotic fragility behavior of Ribavirin loaded erythrocytes 
To evaluate the resistance of erythrocytes membranes against the osmotic pressure 
changes of their surrounding media, 25μl Ribavirin loaded erythrocytes sample was added 
to each of a series of 2.5 ml NaCl solutions containing 0.0 to 0.9 g% of NaCl. After gentle 
mixing and standing for 15 min. at room temperature, the erythrocyte suspensions were 
centrifuged at 5000 rpm for 5 min. The absorbance of the supernatant was measured at 540 
nm 
16
 (Ultraviolet spectrophotometer, Shimadzu 1800(Japan). The released hemoglobin 
was expressed as percentage absorbance of each sample in reference to a completely lysed 
sample prepared by diluting of packed cells with 1.5 ml of distilled water. An osmotic 
fragility index was defined for native and Ribavirin loaded erythrocytes. 
Scanning electron microscopy (SEM) 
The scanning electron micrographs were illustrated for Ribavirin loaded 
erythrocytes by endocytosis method at x4300 and x7000 magnifications. (JOEL scanning 
electron microscope (JTEM) model 1010 Tokyo, (Japan) 
In-Vitro Release of Ribavirin from the loaded erythrocytes  
To study the release of Ribavirin from carrier erythrocytes loaded by the mentioned 
method of loading above, 1 ml of packed Ribavirin loaded erythrocytes was diluted to 9 ml 
using PBS the suspension and then mixed thoroughly by several gentle inversions. The 
mixture was divided into 20 portions (0.5 ml each) in 1.5 ml eppendorff tube. The samples 
were rotated vertically at 20 rpm while incubated at 37
o
C(Oscillating thermostatically 
controlled shaker, Gallent Kamp (England).At (0.5, 2, 4, 8, 12 .16 and 20) hr intervals, one 
of the aliquots was removed and centrifuged at 5000 rpm for 5 min. One hundred μl of the 
supernatants was separated for drug assay. The drug analysis was done by chromatograph. 
  
Effect of cross linker on in-vitro release of Ribavirin loaded erythrocytes 
The release of Ribavirin from erythrocytes loaded by endocytosis after treatment 
with glutaraldehyde as across linker was studied. 
One ml of packed drug loaded erythrocytes was diluted with 8.5 ml of PBS and 0.5 
ml of 0.5% glutaraldehyde solution. The suspension was mixed thoroughly by several 
gentle inversions and incubated for 10 minutes. The mixture was centrifuged and the pellet 
resuspended again in 9 ml PBS and then followed as described above. 
RESULTS and DISCUSSIONS 
Ribavirin uptake by endocytosis 
Table (1) shows the effect of Ribavirin concentrations and the including incubation 
times on the amount of Ribavirin loaded on human carrier erythrocytes by endocytosis at 
37°C. Also table (1) illustrate the effect of Ribavirin concentrations and the including 
incubation times on the Entrapment Efficiency % of Ribavirin loaded on human carrier 
erythrocytes by endocytosis at 37°C.  
Effect of Ribavirin concentration on the loading amount 
Incubation time VS Ribavirin Conc.   
The amount of Ribavirin loaded using Ribavirin concentration 10 mg/ml for 
incubation times 15, 30 and 60 minutes. The amount of Ribavirin loaded is found to reach 
2.72 ± 0.01mg , 2.79 ± 0.024 mgand3.10 ± 0.037 mg , respectively after 15, 30 and 60 
minutes of incubation. It was found that the amount of Ribavirin loaded increases in direct 
proportionality according to the time factor till reaching the maximum loading incubation 
time after 60 minutes (r = 0.987). 
Upon increasing Ribavirin concentration to 15 mg/ml for the same times mentioned 
above, the amount of Ribavirin loaded is found to be 3.61 ± 0.02mg, 3.68 ± 0.01mg and 
4.68 ±0.033 mg, respectively after the same time mentioned above. Again, Ribavirin 
loaded in erythrocytes increases in direct proportionality by increasing the time factor (r = 
0.962).  
By increasing Ribavirin concentration to 20 mg/ml for the same times, the amount 
of drug loaded is also significantly increased according to the time factor increase till 
reaching the maximum loading time after 60 minutes.The amount of Ribavirin loaded 
observed was as follows: 3.65± 0.012mg, 5.1± 0.023 mgand5.66± 0.04mg, 
respectively.Ribavirin loaded in erythrocytes increases in direct proportionality by 
increasing the time factor (r = 0.905).  
By increasing Ribavirin concentration to become 25 mg/ml, 30 mg/ml or 35 mg/ml, 
the same phenomena as discussed for (10 mg, 15 mg and 20 mg/ml) was observed and also 
significantly increased according to the time. The maximum loaded amount for all the 
above mentioned concentrations at maximum loading time after 60 minutes was found at 
25 mg/ml. The amount of Ribavirin loaded was as follows: 4.18± 0.012mg, 6.85± 0.019mg 
and 9.58± 0.045mg, respectively; 4.54 ± 0.01mg, 7.22 ± 0.023 mg and 8.99 ± 0.034 mg, 
respectively for 30 mg/ml of Ribavirin; 4.4 ± 0.012 mg, 7.4 ± 0.026mg and 9.47 ± 0.049 
mg for 35 mg/ml of Ribavirin, respectively. 
The amount of Ribavirin loaded in erythrocytes, in the three mentioned 
concentrations above for Ribavirin, was found to increase in direct proportionality. The 
regression coefficients obtained were r = 0.983, r = 0.953 and r = 0.957, respectively.  
Ribavirin Conc. VS each incubation time 
The amount of Ribavirin loaded using all the applied Ribavirin concentrations 
(from 10 mg/ml to 35 mg/ml) for each applied incubation time (15 min., 30 min. and 60 
min) i.e., at constant time in each experiment. 
  
The amount of Ribavirin loaded at 15 min. was found to be 2.27 ±0.01 mg, 3.61 ± 
0.02 mg, 3.65 ± 0.012 mg, 4.18 ± 0.012 mg, 4.54 ± 0.01 mg and 4.4 ± 0.012 mg, 
respectively for the six Ribavirin concentrations. The above relationship shows a direct 
proportionality with r = 0.931. 
The amount of Ribavirin loaded at 30 min. was found to be 2.79± 0.024 mg, 3.68± 
0.01 mg, 5.1± 0.023 mg, 6.85 ± 0.019 mg, 7.22 ± 0.023 mg and 7.4 ± 0.026 mg, 
respectively for the six Ribavirin concentrations. The above relationship shows a direct 
proportionality with r = 0.965.      
The amount of Ribavirin loaded at 60 min. was found to be 3.1± 0.037 mg, 4.68± 
0.033 mg, 5.66± 0.04 mg, 9.58 ± 0.045 mg, 8.99 ± 0.034 mg and 9.47 ± 0.049 mg, 
respectively for the six Ribavirin concentrations. The above relationship shows a direct 
proportionality with r = 0.931. 
Effect of Ribavirin concentrations on the entrapment efficiency% 
Incubation time VS Ribavirin Conc.   
The entrapment efficiency% of Ribavirin loaded using Ribavirin concentration 10 
mg/ml for times 15, 30 and 60 minutes. The entrapment efficiency % of Ribavirin loaded 
was found to reach 27.2%, 27.95% and 31%, respectively after 15, 30 and 60 minutes of 
incubation. It was found that the entrapment efficiency% of Ribavirin loaded increases in 
direct proportionality according to the time factor till reaching the maximum loading 
incubation time after 60 minutes (r = 0.989). 
Upon increasing Ribavirin concentration to 15 mg/ml for the same times mentioned 
above, the entrapment efficiency % of Ribavirin loaded was found to be 24%, 25.7% and 
31.1%, respectively after the same time mentioned above. Again, the entrapment 
efficiency% of Ribavirin loaded into erythrocytes increases in direct proportionality by 
increasing the time factor (r = 0.994).  
By increasing Ribavirin concentration to 20 mg/ml for the same times, the 
entrapment efficiency % of Ribavirin loaded was also significantly increased according to 
the time factor increase till reaching the maximum loading time after 60 minutes.The 
entrapment efficiency % of Ribavirin loaded observed was as follows: 18.3 %, 25.5 %and 
28.3 %, respectively.The entrapment efficiency % of Ribavirin loaded in erythrocytes 
increases in direct proportionality by increasing the time factor (r = 0.905).  
By increasing Ribavirin concentration to become 25 mg/ml, 30 mg/ml or 35 mg/ml, 
the same phenomena as discussed for (10 mg, 15 mg and 20 mg/ml) was observed and also 
significantly increased according to the time. The maximum entrapment efficiency % of 
Ribavirin loaded for all the above mentioned concentrations at maximum loading time 
after 60 minutes was found at 25 mg/ml. The amount of Ribavirin loaded was as follows: 
16.7 %, 27.4 % and 38.3 %, respectively; 15.2 %, 24 % and 29.9 %, respectively for 30 
mg/ml of Ribavirin; 12.6 %, 21.1 % and 27 % for 35 mg/ml of Ribavirin, respectively. 
The entrapment efficiency % of Ribavirin loaded into erythrocytes, in the three 
mentioned concentrations above for Ribavirin, was found to increase in direct 
proportionality. The regression coefficients obtained were r = 0.983, r = 0.954 and r = 
0.957, respectively. 
Ribavirin Conc. VS each incubation time 
The entrapment efficiency % of Ribavirin loaded using all the applied Ribavirin 
concentrations (from 10 mg/ml to 35 mg/ml) for each applied incubation time (15 min., 30 
min. and 60 min) i.e., at constant time in each experiment. The entrapment efficiency % of 
Ribavirin loaded at 15 min. was found to be 27.2 %, 24 %, 18.3 %, 16.7 %, 15.2 % and 
12.6 %, respectively for the six Ribavirin concentrations. The above relationship shows an 
inverse proportionality with r = -0.974.      
  
The entrapment efficiency % of Ribavirin loaded at 30 min. was found to be 27.95 
%, 25.7 %, 25.5 %, 27.4 %, 24 % and 21.1 %, respectively for the six Ribavirin 
concentrations. The above relationship shows an inverse proportionality with r = - 0.804. 
The above results indicate that the entrapment efficiency % of Ribavirin was decreased 
from 10 mg/ml until 20 mg/ml of Ribavirin and then increased in Ribavirin concentration 
of 25 mg/ml followed by a decrease again in the remaining Ribavirin concentrations. 
The entrapment efficiency % of Ribavirin loaded at 60 min. was found to be 31.0 
%, 31.2 %, 28.3 %, 38.3 %, 29.9 % and 27.0 %, respectively for the six Ribavirin 
concentrations. The above relationship shows an inverse proportionality with r = -0.188. 
These results confirmed the same phenomenon as described above.  
The experimental work investigates the effect of time, as well as the drug 
concentration on the process of Ribavirin loading into human erythrocytes by endocytosis 
as trial to obtain Ribavirin targeted delivery system. The results indicate that the highest 
level of Ribavirin loaded on erythrocytes was achieved using 25 mg/ml of Ribavirin at 
37
o
C and 60 minutes incubation time. 
The aforementioned results proved compatible with  the previous study which 
demonstrates the increase in the cell membrane activity upon temperature increasing up to 
optimum temperature 37
o
C (Solomon et al.; 2010). Likewise, this finding is supported by 
another study which shows that endocytosis process is decreased by decreasing 
temperature 
18
. The presence of some factors as tonicity factor or an energy source 
stimulates the endocytosis 
19
. 
The presence of calcium ions and ATP in the formulation process stimulates the 
endocytosis of Ribavirin uptake by erythrocytes. This is supported by the observation 
viewed by Schrier et al., (1977) which stated that the calcium ions and energy source 
stimulate drug uptake by erythrocytes through membrane invagination and formation of 
endocytotic vacuoles. The drugs induced endocytosis is dependent on the persistence of 
erythrocyte energy sources 
20
. 
This finding coincides with results reported by Millán et al., (2008); Hamidi et al., 
(2007a) and Hamidi et al., (2007b). 
From the above results was found that the highest entrapment efficiency % of 
Ribavirin loaded was 38.3 % that was given at 25 mg/ml of Ribavirin after 60 minutes 
incubation time. After that the entrapment efficiency % of Ribavirin loaded was decreased 
upon increasing Ribavirin concentration. This entrapment efficiency % of Ribavirin 
loading is better than that obtained in interferon-alpha 2b  loading study as comparison 
(Hamidi et al.; 2007). 
Hematological indicesof loaded erythrocytes uptake by endocytosis 
Table (2) represents the mean hematological parameters of the Ribavirin loaded 
erythrocytes obtained with 25 mg/ml Ribavirin concentration and values for the same cells 
before the loading procedures (the control cells) and after loading process but without 
using drug (sham encapsulated). It was found that the change in hematological parameters 
is significant at (p≤ 0.01). 
The hematological parameters, such as MCV, MCH and MCHC were 
characterized. These parameters determine the influence of the encapsulation process on 
the hematological properties of the erythrocytes(Millán et al.; 2008). The results show 
changes in hematological parameters were observed at higher concentrations (25 mg/ml). 
From these data, Ribavirin loading into erythrocytes occurs either by encapsulation or 
binding to the cell membrane 
1
.Data shows significant changes in MCV in Ribavirin 
loaded erythrocytes was (85.1 ± 1.92) but sham encapsulated (79 ± 1.78) was similar to 
  
control (78.6 ± 1.54).This indicate that the change in loaded erythrocytes is related to the 
effect of the drug and the loading procedure has no effect. 
This finding was in agreement with previous report (Briones et al.; 2010). There 
were also slight changes in both MCH and MCHC that appear only in Ribavirin loaded 
erythrocytes (25.0 ± 0.84 and 29.4 ± 0.92) respectively.   
These changes can be explained by Ribavirin have minimal oxidative injury of 
erythrocytes membrane that cause a physical and/or functional barrier of erythrocyte, 
therefore hemoglobin loss is easier from carrier erythrocytes. 
This finding was in agreement with Preparation of carrier erythrocytes for RES-
targeted delivery of interferon-alpha 2b ( Hamidi et al.; 2007).These predictions were 
supported by the SEM analysis data and osmotic fragility that will discussed later. 
Cell recovery of erythrocytes uptake by Endocytosis method  
The percentage ratio of the hematocrite value of the final loaded cells to that of the 
initial packed cells was 88.42%. It was determined by hematology analyzer as shown in 
table (2).This result was practically better than the recovery results of other studies such as 
Paclitaxel and Enalapril(Harisa et al.; 2014; Hamidi et al.; 2001).  
Osmotic fragilitybehavior of Ribavirin loaded erythrocytes by endocytosis   
Osmotic fragility determines the susceptibility of erythrocytes to osmotic lysis.  
The obtained results revealed that there was significant difference in the osmotic fragility 
of loaded erythrocyte at 25 mg/ml Ribavirin when compared to that of unloaded 
erythrocytes as graphically represented in figure (1). 
The osmotic fragility of the studied erythrocytes test is a marker of possible 
changes in the integrity of the cell membrane caused by the loading procedure. Moreover, 
the osmotic fragility test measures the resistance of these cells to changes in the osmotic 
pressure of the surrounding media. The osmotic fragility test was carried out by using 
unloaded, sham and Ribavirin loaded erythrocytes. The entrapment of Ribavirin in cells 
significantly decreases the osmotic fragility of the cellsat (p≤ 0.001).and also the osmotic 
fragility of sham erythrocytes decreased in comparison with unloaded erythrocytes 
(control). This may be because of the increased mean corpuscular volume of loaded 
erythrocytes. 
The obtained results in this part indicate that the erythrocytes resist their hemolysis 
process in NaCl percent from 0.90 to 0.50 % and then the hemolysis of the employed 
erythrocytes was increased in fluctuation manner till reach 100% when the NaCl percent 
became 0.00 %. These findings were observed for all the tested specimens, i.e., control, 
sham and Ribavirin loaded erythrocytes. 
So, at 0.50 % NaCl concentration, the osmotic fragility reaches 19.98 ± 1.3 %, 
19.23 ± 1.7 % and 18.50 ± 1.6 % absorbance for control sample, sham and Ribavirin 
loaded erythrocytes, respectively.  By decreasing NaCl concentration from 0.45 to 0.00, 
the osmotic fragility ranges from 48.85 ± 1.8 to 100.00 ± 0.9 for control, ranges from 63.44 
± 2.1 to 100.00 ± 1.0 for sham and ranges from 56.07 ± 1.4 to 100.00 ± 1.0 for Ribavirin 
loaded erythrocytes. 
The osmotic fragility of Ribavirin loaded erythrocytes is decreased by increasing 
NaCl concentration. The obtained correlation coefficients record an inverse proportionality 
between NaCl concentrations (0.0 - 0.9%) and the obtained osmotic fragility of Ribavirin 
loaded erythrocytes, prepared by endocytosis method. The values are - 0.908, - 0.916 and - 
0.924 for control (unloaded), sham and Ribavirin loaded erythrocytes, respectively. 
This may be because of the increased mean corpuscular volume of loaded 
erythrocytes i.e., the values present in table (2) showed that the mean corpuscular volume 
were 78.6 ± 1.54, 79.0 ± 1.78 and 85.1 ± 1.92 for control, sham and Ribavirin loaded 
  
erythrocytes, respectively. The osmotic fragility index for normal erythrocytes was found 
to be 0.486 %w/v, for sham was found to be 0.409 % w/v and for loaded erythrocytes was 
found to be 0.394% w/v. There was a slight decrease in the osmotic fragility value and was 
found to be very negligible to be considered. 
The observed data were in a good agreement with the work done by (Madhavi et 
al.; 2013)who stated that osmotic fragility of Piperine loaded erythrocytes is decreased 
compared with that of unloaded cells and sham erythrocytes. 
The observed results indicate that the osmotic fragility of Ribavirin-loaded 
erythrocytes are affected by two factors, loading process and Ribavirin as drug cause 
change in erythrocytes membrane. This result was approved and clearly evidentby 
scanning electron microscope which be discussed latter in this paper.The accumulation of 
Ribavirin triphosphate in red blood cells (RBCs). Ribavirin triphosphate accumulation 
leads to a relative adenosine triphosphate (ATP) deficiency in the RBCs. The associated 
depletion of its ATP may damage the antioxidant defense system and induce some RBC 
membrane changes such as oxidative injury, promoting intraerythrocyte oxidative stress 
with subsequent membrane injury, and that these injured erythrocytes then undergo 
physiological extravascular destruction by the reticuloendothelial system. 
This interpretation was supported by other  previous studies stated that Ribavirin 
induce changes in erythrocytes membrane preserve consequently changes in  fragility and 
morphology (Tanaka et al.; 2005; Russmann et al.; 2006). 
The loading process and/or the drug have deleterious effects on erythrocyte shape. 
The change of carrier cells morphology from the native cells gives the opportunity for 
carrier erythrocytes to phagocytosed into reticuloendothelial system
3
. This result suggested 
that loaded erythrocytes can be used for targeting of Ribavirin. This assumption is 
supported by previous findings which recommended that the use of carrier erythrocytes as 
targeting system for Piperine due to the distinct effect changes in drug loaded erythrocytes 
morphology which make drug loaded erythrocytes easily removed by 
macrophages(Madhavi et al.; 2013). 
In-vitro release of Ribavirin loaded erythrocytes obtained by endocytosis method 
In vitro Release in PBS pH 7.4 
Figure (2) represents the in-vitro release of Ribavirin from loaded erythrocytes in 
PBS pH 7.4 over a 20 hrs. An initial burst release was obtained over the first 2 hrs (52.2% 
from loaded amount of Ribavirin).From the obtained results, there was a rapid release of 
52% of Ribavirin within the first 2 hrs indicating that, the drug may be bound on to the 
surface of the membrane which was released quickly. Then the amount of Ribavirin 
released increased gradually to reach 88% of the loaded Ribavirin within 20hrs as observed 
in figure (2). 
In-vitro release in PBSpH 7.4after treatment with glutaraldehyde 
Figure (2) shows the in-vitro release of Ribavirin behavior from loaded 
erythrocytes by endocytosis in PBS pH 7.4 after using glutaraldehyde as a membrane 
stabilizer. Figure (2) shows the results of studying the effect of cross-linking agent on the 
releasing of Ribavirin loaded by endocytosis method. It was clear that the glutaraldehyde 
reduces the releasing of Ribavirin from Ribavirin loaded erythrocytes, the release after 20 
hrs reached 21.77 %. 
Release Kinetics of Ribavirin Loaded Erythrocytes by endocytosis method  
From the obtained releasing data, the coefficient of correlation (r) for zero order, 
first order and Higuchi diffusion model were found to be 0.8428, 0.8428 and 
0.9393respectively, for the release ofRibavirin Loaded Erythrocytes by endocytosis 
methodand to be 0.9249, 0.3840 and 0.9744 for the release ofRibavirin Loaded 
  
Erythrocytes by endocytosis methodafter adding glutaraldehyde as membrane stabilizer 
indicating Ribavirin release from loaded erythrocytes undergo diffusion order.  
Therefore, the efflux of Ribavirin from carrier cells followed diffusion kinetics 
during the entire experimental period. 
Scanning electron microscopyof Ribavirin loaded erythrocytes by endocytosis method 
Figures (3 and 4) show the scanning electron micrographs of unloaded erythrocytes 
and figures (5 and 6) show Ribavirin loaded erythrocytes by endocytosis method, both at 
x4300 and x7000 magnification. 
From the SEM pictures of unloaded figures (3 and 4) and Ribavirin loaded 
erythrocytes (5 and 6), it's clearly observed that, unloaded normal erythrocytes, the cell 
surface is smooth and Ribavirin loaded erythrocytes, the cell surface is rough with small 
lesions. The diameter of the unloaded erythrocytes was around 4µm and after loading there 
was an increase in the diameter of the erythrocytes around 5µm. The loaded erythrocytes 
are more enlarged and irregular in shape than biconcave shape with slight damage of the 
surface. On conclusion there are significant changes in the cell surface and morphology of 
Ribavirin loaded erythrocytes this may be due to minimal oxidative effect of Ribavirin 
drug. Fortunately, these membrane integrity changes make Ribavirin loaded erythrocytes 
much more prone for the phagocytosis by macrophages. 
 The highly changed erythrocyte shape and morphology evidenced in this study, 
being one of the main determinants in erythrocytes disappearance kinetics in circulation, 
can be potentially beneficial in terms of successful cell targeting to RES, which, in turn, 
leads to the improved Ribavirin effects on RES-mediated immune responses and avoidance 
of deleterious side effects of Ribavirin as hemolytic anemia. 
The changes in SEM pictures current work are in a good agreement with the work 
done by (Madhavi et al.; 2013). 
 
Conclusions 
The human erythrocytes were loaded successfully with Ribavirin with the 
practically acceptable loading parameters. The Ribavirin loaded erythrocytes were 
investigated with respect to their in vitro drug delivery characteristics, including drug 
release, loading parameters, hematological indices, shape and morphological properties 
and osmotic fragility. The results of these experiments were indicative of some irreversible 
changes in cell morphology as well as physiology, which, in turn, may favor the cell 
targeting to RES organs. 
The following conclusion can be drawn from the study: 
 The loaded amount of Ribavirin by endocytosis technique ranged from  2.72 ± 0.01 
to 9.58 ± 0.045) mg/ml with entrapment efficiency ranged from (12.6% to 38.3%).The 
maximum loaded amount and entrapment efficiency % ware found to be9.58 ± 0.045and 
38.3%  at 25mg/ml of Ribavirin concentration after 60 minutes incubation time at 37
o
C 
with (88.42%) cell recovery. 
Hematological parameters of Ribavirin loaded erythrocytes significantly differ 
from native erythrocytes at (p≤ 0.01).Where meancorpuscular volume value was increased, 
mean corpuscular hemoglobin and mean corpuscular hemoglobin content values of the 
cells were decreased. 
Osmotic fragility behaviors of Ribavirin loaded erythrocytes obtained by 
endocytosis were significantly decreased in comparison with native erythrocytes at (p≤ 
0.001). 
  
Ribavirinin-vitro released from carrier cells prepared by endocytosis in PBS pH 7.4 
was a relatively rapid process where theinitial burst release obtained over the first 2 hrs. 
(52.2%) from loaded amount of Ribavirin then the efflux of Ribavirin increased gradually 
to reach (87.84%) after 20 hrs.  
In-vitro release in PBS pH 7.4 after treatment with glutaraldehyde cross-linking 
agentshow sustained release of Ribavirin from Ribavirin loaded erythrocytes, after 20 hrs. 
The release was reached to (21.77 %).The efflux of Ribavirin from Ribavirin loaded 
erythrocytes followed diffusion kinetics. 
The scanning electron micrographs of Ribavirin loaded erythrocytes show 
significant changes in the cell surface and morphology with rough cell surface and small 
lesions. This may be due to minimal oxidative effect of Ribavirin drug. Fortunately, these 
remarkable membrane integrity changes make Ribavirin loaded erythrocytes much more 
prone for phagocytosis by macrophages. The considerable changed erythrocyte shape and 
morphology evidenced in this study, being one of the main determinants in erythrocytes 
disappearance kinetics in circulation, can be potentially beneficial in terms of successful 
cell targeting to RES, which in turn leads to the improved Ribavirin effects on RES-
mediated immune responses and consequently diminishing of deleterious adverse effects of 
Ribavirin as hemolytic anemia. 
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Table (1): Effect of Ribavirin concentrations and incubation times on the amount of  
Ribavirin  loaded  on  human  carrier erythrocyte at 37 
o
C by endocytosis 
Drug 
concentration 
(mg/ml) 
Drug incubation times 
15 min. 30 min. 60 min. 
Ribavirin loaded (mg/ml) 
L A EE % LA EE % LA EE % 
10 
2.72 ±  
0.01 
27.2 
 
2.79 ±  
0.024 
27.95 
 
3.1 ±  
0.037
(2)
 
31.0 
 
15 
3.61 ±  
0.02 
24.0 
 
3.68 ±  
0.01 
25.7 
 
4.68 ±  
0.033
(2)
 
31.2 
 
20 
3.65 ±  
0.012 
18.3 
 
5.1 ±  
0.023 
25.5 
 
5.66 ± 
0.04
(2)
 
28.3 
 
25 
4.18 ±  
0.012
(1)
 
16.7 
 
6.85 ±  
0.019
(1)
 
27.4 
 
9.58 ±  
0.045
(1)(2)
 
38.3 
 
30 
4.54 ±  
0.01 
15.2 
 
7.22 ±  
0.023 
24.0 
 
8.99 ±  
0.034
(2)
 
29.9 
 
35 
4.4 ±  
0.012 
12.6 
 
7.4 ±  
0.026 
21.1 
 
9.47 ±  
0.049
(2)
 
27.0 
 
LA = Ribavirin loaded amount, EE% = entrapment efficiency % 
Data is expressed as mean ± SD (n = 3) 
(1) Significantly different according to time at p < 0.001 
(2) Significantly different according to concentration at p < 0.001 
 
 
  
Table (2): Hematological parameters of control erythrocytes, sham and loaded erythrocytes 
obtained with Ribavirin (25mg/ml) by endocytosis 
Hematological 
parameters 
Control Sham encapsulated 
Ribavirin Conc. 
25 mg/ml 
Hct (%) 38 ± 1.16
(2)
 33.8±1.02 33.6 ± 1.37
(2)
 
Mcv (fl) 78.6 ± 1.54
(1)
 79±1.78 85.1 ± 1.92
(1)
 
MCH (pg) 26.1 ± 0.99 26.4±0.87 25.0 ± 0.84 
MCHC (gm/dl) 33.2 ± 1.27
(2)
 33.5±1.18 29.4 ± 0.92
(2)
 
Hematocrite (Hct),Mean corpuscular volume (MCV), Mean corpuscular hemoglobin (MCH), Mean corpuscular hemoglobin 
concentration (MCHC). 
(1) Significantly different from the control at p ≤ 0.01 
(2) Significantly different from the control at p < 0.05 
 
 
